Garrett-BakelmanF. E., et al. (2019). The NASA Twins Study: A multidimensional analysis of a year-long human spaceflight. Science, 364(6436), eaau8650. doi: 10.1126/science.aau8650
2.
HagenbeekF. A., et al. (2023). Maximizing the value of twin studies in health and behaviour. Nature Human Behaviour, 7(6), 849–860. doi: 10.1038/s41562-023-01609-6
3.
HiattR. A. and BeyelerN.. (2020) Cancer and climate change. The Lancet. Oncology, 21(11), e519–e527. doi: 10.1016/S1470-2045(20)30448-4
ZeinomarN., et al. (2020) Environmental exposures and breast cancer risk in the context of underlying susceptibility: A systematic review of the epidemiological literature. Environmental Research.,187, 109346. doi: 10.1016/j.envres.2020.109346
6.
EidemüllerM., et al. (2021) Evidence for increased susceptibility to breast cancer from exposure to ionizing radiation due to a familial history of breast cancer: Results from the Swedish hemangioma cohort. American journal of epidemiology, 190(1), 76–84. doi: 10.1093/aje/kwaa163
7.
MbemiA., et al. (2020). Impact of gene-environment interactions on cancer development. International Journal of Environmental Research and Public Health, 17(21), 8089. doi: 10.3390/ijerph17218089.
8.
HercegZ. and VaissièreT. (2011). Epigenetic mechanisms and cancer: An interface between the environment and the genome. Epigenetics, 6(7), 804–819. doi: 10.4161/epi.6.7.16262
9.
FeehleyT., et al. (2023) Drugging the epigenome in the age of precision medicine. Clinical Epigenetics, 15(16) doi: 10.1186/s13148-022-01419-z
10.
Miranda FurtadoC. L., et al. (2019). Epidrugs: Targeting epi-genetic marks in cancer treatment. Epigenetics, 14(12), 1164–1176. doi: 10.1080/15592294.2019.1640546
11.
ChengY., et al. (2019). Targeting epigenetic regulators for cancer therapy: Mechanisms and advances in clinical trials. Signal Transduction and Targeted Therapy, 4(62). doi: 10.1038/s41392-019-0095-0
12.
BatesS. E. (2020) Epigenetic Therapies for Cancer. The New England Journal of Medicine, 383(7), 650–663. doi: 10.1056/NEJMra1805035
13.
ThakurC., et al. (2022) Epigenetics and environment in breast cancer: New paradigms for anti-cancer therapies. Frontiers in Oncology, 12, 971288. doi: 10.3389/fonc.2022.971288
14.
TaoL., et al. (2024) Epigenetic regulation in cancer therapy: From mechanisms to clinical advances. MedComm Oncology, 3(1), e59. doi: 10.1002/mog2.59
15.
YuanT., et al. (2023). Machine learning in the identification of prognostic DNA methylation biomarkers among patients with cancer: A systematic review of epigenome-wide studies. Artificial Intelligence in Medicine, 143, 102589. doi: 10.1016/j.artmed.2023.102589